Politico also reported, “House Judiciary Chair Jim Jordan said he plans to hold hearings on recent judicial rulings against the Trump administration’s agenda, after President Donald Trump ...

Abstract: A novel wideband antenna with tilted beam patterns and transparent characteristics for vehicle-to-everything (V2X) communication is presented which is composed of a monopole as the radiator, ...

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Beam Global (NASDAQ: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and ...

The issue is that six years ago, Prime appeared to sign away its rights to create AATD treatments to another company it has long collaborated with, Beam Therapeutics.

Sir Jim Ratcliffe has named the one manager Manchester United have hired in the post Sir Alex Ferguson era that he would not have appointed. The legendary Scot stood down in 2013 after leading the ...

The firm will replace door button assemblies in more than 7,000 vehicles free of charge Ineos Automotive, the car maker owned by Manchester United co-owner, Sir Jim Ratcliffe, has recalled more ...

Jim Beam, the retired editor of the American Press, has covered people and politics for more than six decades. Contact him at 337-515-8871 or [email protected].

Sir Jim Ratcliffe is convinced a struggling Manchester United star will ‘come good’ eventually despite a difficult start to life in the Premier League. United are enduring one of the worst ...

Beam logo CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today ...

CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Beam Therapeutics (BEAM) announced initial safety and efficacy data from its Phase 1/2 trial of BEAM-302, establishing clinical proof-of-concept as a potential treatment for alpha-1 antitrypsin ...